Jack Nielsen
InvestorFounderManaging Partner at Vivo Capital · Board director at Instil Bio · Board director at Aligos Therapeutics · Board director at Harmony Biosciences
Palo Alto, California
Writes $10M – $50M checks · typically $25M
About
Jack Nielsen is a Managing Partner at Vivo Capital with over two decades of experience in life science venture capital investing. He focuses on therapeutics across all development stages and revenue-stage medical devices, with geographic emphasis on the US and EU markets.
Board director at Instil Bio
Intro paths
In turn, Jack can intro founders to Instil Bio's investors below.
Instil Bio's investors · 2
Co-founders at Instil Bio
Board director at Aligos Therapeutics
Intro paths
In turn, Jack can intro founders to Aligos Therapeutics's investors below.
Aligos Therapeutics's investors · 3
Co-founders at Aligos Therapeutics
Board director at Harmony Biosciences
Intro paths
In turn, Jack can intro founders to Harmony Biosciences's investors below.
Harmony Biosciences's investors · 5
Co-founders at Harmony Biosciences
Experience
- Vivo CapitalManaging Partnercurrent2017 — presentPalo Alto
- Vivo CapitalConsultant2017Copenhagen Metropolitan Area
- Ocelot BioBoard Membercurrent2021 — present
- IO BiotechBoard Membercurrent2021 — presentCopenhagen, Capital Region of Denmark, Denmark
- Instil BioBoard Membercurrent2020 — present
- ALX OncologyBoard Membercurrent2020 — present
- Aligos TherapeuticsChairman / Lead Directorcurrent2018 — present
- HARMONY BIOSCIENCESBoard Membercurrent2017 — presentUnited States
- Reata PharmaceuticalsLead Director - Board Member2006 — 2022Dallas-Fort Worth Metroplex
- MacuLogix - The AMD ExpertsBoard Member2019 — 2022
- Passage BioBoard Observer2018 — 2020
- Crinetics PharmaceuticalsBoard Member2018 — 2019San Diego
- MerusBoard Member2015 — 2017The Randstad, Netherlands
- Apollo EndosurgeryBoard Member2012 — 2017Austin, Texas Metropolitan Area
- Procept BioRoboticsBoard Member2015 — 2017San Francisco Bay Area
- Kanyos BioBoard Member2015 — 2017Greater Boston
- Unchained LabsBoard Member2015 — 2017San Francisco Bay Area
- Anokion SABoard Member2014 — 2017Lausanne, Vaud, Switzerland
- Novo A/SSenior Partner2001 — 2017
- Akebia TherapeuticsBoard Member2013 — 2015Greater Boston
- Alios BioPharmaChairman2008 — 2014south san francisco
- ProteinSimpleBoard Member2006 — 2014Santa Clara, California
- Tobira Therapeutics, Inc.Board Member2010 — 2014San Francisco Bay Area
- NeomendBoard Member2007 — 2012Irvine
- CardioOpticsBoard Member2005 — 2007
- NuevolutionBoard Member2001 — 2005
- Panacos PharmaceuticalsBoard Member2004 — 2005
- NovozymesManager1990 — 2001
Education
- DTU - Technical University of DenmarkMMT/MBA, Mgt of Technology and Economics1998 — 2000
- DTU - Technical University of DenmarkMSc, Chemistry1984 — 1990
- Herlev Statskole1980 — 1983
Skills & more
+12 more
OncologyDue DiligenceBiopharmaceuticalsClinical TrialsCorporate DevelopmentProduct DevelopmentBusiness StrategyFDAPharmaceutical IndustryBiochemistryMergers & AcquisitionsLife SciencesFrom Jack's professional profile.
Deals · 5
Aligos TherapeuticsBoard seat
via Vivo Capital · filed Nov 2023 · $92.2M raise
MediaspaceBoard seat
via Vivo Capital · filed Dec 2021 · $22M raise
REATA PHARMACEUTICALS INCBoard seat
via Vivo Capital · filed Jun 2020 · $50M raise
Harmony BiosciencesBoard seat
via Vivo Capital · filed Aug 2019 · $50M raise
Crinetics Pharmaceuticals, Inc.Board seat
via Vivo Capital · filed Feb 2018 · $65M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at Vivo Capital
Network1
Investors connected to Jack in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Jack Nielsen?
- Jack Nielsen is a Managing Partner at Vivo Capital with over two decades of experience in life science venture capital investing. He focuses on therapeutics across all development stages and revenue-stage medical devices, with geographic emphasis on the US and EU markets.
- Where does Jack Nielsen work?
- Jack Nielsen is Managing Partner at Vivo Capital and Board director at Instil Bio and Board director at Aligos Therapeutics and Board director at Harmony Biosciences.
- What check size does Jack Nielsen write?
- Jack Nielsen typically writes checks of $10M – $50M.
- What boards does Jack Nielsen sit on?
- Jack Nielsen holds tracked board seats at Aligos Therapeutics, Crinetics Pharmaceuticals, Inc., Harmony Biosciences, Mediaspace, REATA PHARMACEUTICALS INC.
- Where did Jack Nielsen go to school?
- Jack Nielsen studied at DTU - Technical University of Denmark (MMT/MBA, Mgt of Technology and Economics); DTU - Technical University of Denmark (MSc, Chemistry); Herlev Statskole.
Same school
Also attended DTU - Technical University of Denmark64
+ 58 more
